Organic cation transporter 3 on neuronal mitochondria mediates MPP + -induced mitochondrial dysfunction and neurotoxicity in a TIMM22-dependent manner.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory study in a human cell line (mechanism-based bench research).
PubMed 40660178 · doi:10.1186/s12915-025-02318-4
What was done
Investigated the localization and transport function of organic cation transporter 3 (OCT3) on mitochondria in cultured human SH-SY5Y neuroblastoma cells. The authors assessed mitochondrial MPP+ uptake with and without pharmacological OCT3 inhibition. They also knocked down the mitochondrial protein import component TIMM22 (translocase of inner mitochondrial membrane 22) to evaluate its impact on mitochondrial OCT3 abundance, MPP+ uptake, mitochondrial fragmentation, complex I activity, mitochondrial membrane potential, and apoptotic markers (caspase-3/9, BAX, and BCL-xL).
What was found
The abstract reports qualitative directions of effect without numerical values or statistical metrics. OCT3 localized to both the inner and outer mitochondrial membranes. Mitochondrial MPP+ uptake increased after MPP+ exposure and was mitigated by OCT3 inhibition. TIMM22 knockdown reduced mitochondrial OCT3 levels without altering baseline mitochondrial morphology or membrane potential. Consequently, TIMM22 knockdown reduced mitochondrial MPP+ uptake, rescued MPP+-induced mitochondrial fragmentation, complex I inhibition, and membrane potential reduction, and reversed pro-apoptotic signaling (suppressed caspase-3/9 activation and normalized BAX and BCL-xL alterations).
Why it matters
This study defines a mechanism by which the neurotoxin MPP+ enters mitochondria via OCT3 and shows that TIMM22-mediated import regulates mitochondrial OCT3 abundance. It suggests TIMM22 and OCT3 may serve as molecular targets for mitigating mitochondrial dysfunction in toxin-associated neurodegeneration models.
Limits
All findings derive from an in vitro neuroblastoma cell line (SH-SY5Y) without confirmation in primary dopaminergic neurons or in vivo animal models. The abstract reports no numerical values, concentrations, effect sizes, or variance measures. Potential off-target or broad physiological consequences of TIMM22 knockdown beyond OCT3 reduction were not detailed in the abstract.
Cited by
- supports MPP+, the active metabolite of MPTP, causes mitochondrial toxicity by damaging complex I of the electron transport chain.